AI in Healthcare

The promise of AI in healthcare, particularly drug discovery, often hits a wall when faced with fragmented biological data. What if the missing piece wasn't bigger models, but better contextual data? MindWalk Holdings Corp. recently showcased their ReefIQ platform, which aims to provide this critical biological context. Their LensAI, for instance, has meticulously curated 660 million biological patterns and 25 billion relationships over two decades, enabling AI to reason more effectively over complex biological questions. This development, highlighted at AMD's Advancing AI 2026 event, could be pivotal in accelerating the identification and development of novel therapies. How do you see the integration of such contextual AI platforms impacting the speed and success rate of drug discovery in the next few years? Share your thoughts below. Source: MindWalk Holdings Corp., 'MindWalk Showcases ReefIQ for AI Drug Discovery at AMD Advancing AI,' press release, July 23, 2026, referenced in 'A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed,' published July 24, 2026. (URL: https://www.mindwalk.com/news/reefiq-amd-ai-2026) View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google and IBM-Trained. Cross Domain-Expert. Quantum AI Educator. Solepoint (Facts Already Defined) Strategic Practitioner. Real Estate Intelligence Leader. VUI Native AI Cloud Architect. AI Certifications Development. George Arnold Alexander III Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC +1 713.918.9951 · [email protected]